These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9609114)

  • 41. Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins.
    Solow BT; Harada S; Goldstein BJ; Smith JA; White MF; Jarett L
    Mol Endocrinol; 1999 Oct; 13(10):1784-98. PubMed ID: 10517679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin-independent and wortmannin-resistant targeting of IRS-3 to the plasma membrane via its pleckstrin homology domain mediates a different interaction with the insulin receptor from that of IRS-1.
    Kaburagi Y; Satoh S; Yamamoto-Honda R; Ito T; Ueki K; Akanuma Y; Sekihara H; Kimura S; Kadowaki T
    Diabetologia; 2001 Aug; 44(8):992-1004. PubMed ID: 11484076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats.
    Saad MJ; Folli F; Kahn JA; Kahn CR
    J Clin Invest; 1993 Oct; 92(4):2065-72. PubMed ID: 7691892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin receptor substrate-4 signaling in quiescent rat hepatocytes and in regenerating rat liver.
    Escribano O; Fernández-Moreno MD; Zueco JA; Menor C; Fueyo J; Ropero RM; Diaz-Laviada I; Román ID; Guijarro LG
    Hepatology; 2003 Jun; 37(6):1461-9. PubMed ID: 12774026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of alterations in insulin signalling pathway in adipocytes from Type II diabetic pregnant women and women with gestational diabetes mellitus.
    Tomazic M; Janez A; Sketelj A; Kocijancic A; Eckel J; Sharma PM
    Diabetologia; 2002 Apr; 45(4):502-8. PubMed ID: 12032625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin receptor substrates 1 and 2 but not Shc can activate the insulin receptor independent of insulin and induce proliferation in CHO-IR cells.
    Niessen M; Jaschinski F; Item F; McNamara MP; Spinas GA; Trüb T
    Exp Cell Res; 2007 Feb; 313(4):805-15. PubMed ID: 17222824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
    Le MN; Kohanski RA; Wang LH; Sadowski HB
    Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steered Molecular Dynamics for Investigating the Interactions Between Insulin Receptor Tyrosine Kinase (IRK) and Variants of Protein Tyrosine Phosphatase 1B (PTP1B).
    Nguyen H; Do N; Phan T; Pham T
    Appl Biochem Biotechnol; 2018 Feb; 184(2):401-413. PubMed ID: 28707052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of insulin dissociation from its endosomal receptor in insulin degradation.
    Bevan AP; Seabright PJ; Tikerpae J; Posner BI; Smith GD; Siddle K
    Mol Cell Endocrinol; 2000 Jun; 164(1-2):145-57. PubMed ID: 11026566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Internalization and localization of basal insulin peglispro in cells.
    Moyers JS; Volk CB; Cao JXC; Zhang C; Ding L; Kiselyov VV; Michael MD
    Mol Cell Endocrinol; 2017 Oct; 454():23-38. PubMed ID: 28576743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin internalization and other signaling pathways in the pleiotropic effects of insulin.
    Smith RM; Harada S; Jarett L
    Int Rev Cytol; 1997; 173():243-80. PubMed ID: 9127955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early steps in insulin action.
    Dorrestijn J; van Bussel FJ; Maassen JA; Gomes de Mesquita DS
    Arch Physiol Biochem; 1998 Oct; 106(4):269-89. PubMed ID: 10417854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intracellular signal transduction: The role of endosomes.
    Bevan AP; Drake PG; Bergeron JJ; Posner BI
    Trends Endocrinol Metab; 1996; 7(1):13-21. PubMed ID: 18406720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of receptor internalization in insulin signalling.
    Frost SC; Risch R
    Adv Exp Med Biol; 1991; 293():215-25. PubMed ID: 1767732
    [No Abstract]   [Full Text] [Related]  

  • 55. Logical analysis of timing-dependent receptor signalling specificity: application to the insulin receptor metabolic and mitogenic signalling pathways.
    Shymko RM; De Meyts P; Thomas R
    Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):463-9. PubMed ID: 9291119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The endosomal apparatus and transmembrane signalling.
    Bergeron JJ; Lai WH; Kay DG; Doherty JJ; Khan MN; Posner BI
    Adv Exp Med Biol; 1988; 234():213-24. PubMed ID: 3063087
    [No Abstract]   [Full Text] [Related]  

  • 57. Insulin degradation: progress and potential.
    Duckworth WC; Bennett RG; Hamel FG
    Endocr Rev; 1998 Oct; 19(5):608-24. PubMed ID: 9793760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin resistance as the molecular link between diabetes and Alzheimer's disease.
    Abdalla MMI
    World J Diabetes; 2024 Jul; 15(7):1430-1447. PubMed ID: 39099819
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular Mechanisms for the Vicious Cycle between Insulin Resistance and the Inflammatory Response in Obesity.
    Szukiewicz D
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Downregulation of Opioid Receptors and Neuropathic Pain.
    Li L; Chen J; Li YQ
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.